A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.
In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.
The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.
The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.
Seeking Standards for Microbial Loads in Healthcare Facilities
UCR Health Unveils Plans for Major Expansion
High-Performance Windows Support Safety at UW Medicine's New Behavioral Health Center
Central Maine Healthcare Dealing with IT System Outage
Kaiser Permanente Opens Newly Expanded Everett Medical Center